Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

U.S. administers 468.5 million doses of COVID-19 vaccines- CDC

Stock MarketsDec 04, 2021 04:30PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: Syringes with a dose of the coronavirus disease (COVID-19) vaccine are ready for injections at a vaccine clinic at La Colaborativa in Chelsea, Massachusetts, U.S., November 30, 2021. REUTERS/Brian Snyder

(Reuters) - The United States had administered 468,516,782 doses of COVID-19 vaccines in the country as of Saturday morning and distributed 581,107,805 doses, the U.S. Centers for Disease Control and Prevention said.

Those figures are up from the 466,348,132 vaccine doses the CDC said had gone into arms by Dec. 3 out of 580,893,145 doses delivered.

The agency said 235,297,964 people had received at least one dose, while 198,592,167 people had been fully vaccinated as of 6:00 a.m. ET on Saturday.

The CDC tally includes two-dose vaccines from Moderna (NASDAQ:MRNA) and Pfizer/BioNTech,, as well as Johnson & Johnson (NYSE:JNJ)'s one-shot vaccine.

About 45.3 million people have received a booster dose of either Pfizer (NYSE:PFE), Moderna or Johnson & Johnson's COVID-19 vaccine. Booster doses from Moderna and Johnson & Johnson were authorized by the U.S. health regulator on Oct. 20.

U.S. administers 468.5 million doses of COVID-19 vaccines- CDC
 

Related Articles

French parliament approves vaccine pass
French parliament approves vaccine pass By Reuters - Jan 16, 2022 6

PARIS (Reuters) - France's parliament gave final approval on Sunday to the government's latest measures to tackle the COVID-19 virus, including a vaccine pass contested by...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (5)
ZS Beck
ZS Beck Dec 04, 2021 10:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
435 million doses later, 100 cases daily. What a success story
Todd Gray
Todd Gray Dec 04, 2021 9:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
We have not had one single day of covid-19 deaths that has exceeded the daily death rate average for all underlying causes throughout the entire 4 years preceding covid-19. Certainly some have died of those underlying causes, and didn't have covid. But, how many more than normal is a big unanswered question. Taking out the overdose & suicide increases, and backing out all the people who died in cars, or household accidents, etc., but had covid & were tallied as covid deaths, that total the clear picture. And, nobody's giving those figures to us.
John Laurens
John Laurens Dec 04, 2021 8:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
aaand omicron xi morphs with the common cold and makes fools of the entire world. At least big pharma got rich and fascists gained power sooo… might have been worth it.
HD HD
HD HD Dec 04, 2021 6:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
so when do we begin to collapse anti vax crowd ? us sheep are supposed to collapse right ? only ones left are the uncontrollable ? lol
Mike Blade
Mike Blade Dec 04, 2021 6:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
fake news
Rob Whalen
Rob Whalen Dec 04, 2021 6:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Still 99.96% recovery rate 💪🏻
John Laurens
John Laurens Dec 04, 2021 6:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Rob Whalen  EXACTLY!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email